The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Ethyl (E)-6-chloro-3-((2-(2-(pyridin-3-yl)acetyl)hydrazineylidene)methyl)-1H-indole-2-carboxylate ID: ALA4474382
PubChem CID: 155536874
Max Phase: Preclinical
Molecular Formula: C19H17ClN4O3
Molecular Weight: 384.82
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCOC(=O)c1[nH]c2cc(Cl)ccc2c1/C=N/NC(=O)Cc1cccnc1
Standard InChI: InChI=1S/C19H17ClN4O3/c1-2-27-19(26)18-15(14-6-5-13(20)9-16(14)23-18)11-22-24-17(25)8-12-4-3-7-21-10-12/h3-7,9-11,23H,2,8H2,1H3,(H,24,25)/b22-11+
Standard InChI Key: YNNPMYLHWVPUDB-SSDVNMTOSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
27.3951 -4.2469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3940 -5.0664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1020 -5.4754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1002 -3.8380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8089 -4.2433 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8091 -5.0665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5921 -5.3206 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.0758 -4.6545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5917 -3.9887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6860 -5.4745 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
30.8930 -4.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3018 -5.3618 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.3013 -3.9463 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.1190 -5.3615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5279 -6.0690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8439 -3.2115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6432 -3.0413 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.8955 -2.2640 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.6948 -2.0939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9471 -1.3166 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.2418 -2.7010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0411 -2.5308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5843 -3.1417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3829 -2.9720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6358 -2.1941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0840 -1.5856 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.2875 -1.7584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
2 10 1 0
8 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 1 0
9 16 1 0
16 17 2 0
17 18 1 0
18 19 1 0
19 20 2 0
19 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 384.82Molecular Weight (Monoisotopic): 384.0989AlogP: 3.09#Rotatable Bonds: 6Polar Surface Area: 96.44Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.97CX Basic pKa: 4.87CX LogP: 2.71CX LogD: 2.71Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.39Np Likeness Score: -1.64
References 1. van der Vlag R, Guo H, Hapko U, Eleftheriadis N, Monjas L, Dekker FJ, Hirsch AKH.. (2019) A combinatorial approach for the discovery of drug-like inhibitors of 15-lipoxygenase-1., 174 [PMID:31026746 ] [10.1016/j.ejmech.2019.04.021 ]